|
European Organisation For Research And Treatment Of Cancer
The European Organisation for Research and Treatment of Cancer (EORTC) is a unique pan-European non-profit clinical cancer research organisation established in 1962 operating as an international association under Belgium law. It develops, conducts, coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer patients. This is achieved through the development of new drugs and other innovative approaches, and the testing of more effective therapeutic strategies, using currently approved drugs, surgery and/or radiotherapy in clinical trials conducted under the auspices of a vast network of clinical cancer researchers supported by 220 staff members based in Brussels. The EORTC has the expertise to conduct large and complex trials especially specific populations such as the older patient and rare tumours. Mission, achievements, and network The EORTC's mission is to increase people's survival and quality of li ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
European Cancer Organisation
The European Cancer Organisation is a not-for-profit federation of 41 Member Societies working in cancer at a European level, together with 20 European Patient Advisory Committee members. The Organisation is dedicated to convening oncology professionals and patients to agree policy, advocate for positive change and speak for the European cancer community. The European Cancer Organisation is the organiser of the annual European Cancer Summit. Mission statement The Mission of the European Cancer Organisation is to reduce the burden of cancer, improve outcomes and the quality of care for cancer patients, through multidisciplinarity and multiprofessionalism. As the not-for-profit federation of member organisations working in cancer at a European level, the European Cancer Organisation convenes oncology professionals and patients to agree policy, advocate for positive change and be the united voice of the European cancer community. Background and current organisation In the ea ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Radiotherapy
Radiation therapy or radiotherapy, often abbreviated RT, RTx, or XRT, is a therapy using ionizing radiation, generally provided as part of cancer treatment to control or kill malignant cells and normally delivered by a linear accelerator. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body. It may also be used as part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a primary malignant tumor (for example, early stages of breast cancer). Radiation therapy is synergistic with chemotherapy, and has been used before, during, and after chemotherapy in susceptible cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology. A physician who practices in this subspecialty is a radiation oncologist. Radiation therapy is commonly applied to the cancerous tumor because of its ability to control cell growth. Ionizing radiation works by damaging the DNA of cancerous tissue l ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Oncology
Oncology is a branch of medicine that deals with the study, treatment, diagnosis and prevention of cancer. A medical professional who practices oncology is an ''oncologist''. The name's etymological origin is the Greek word ὄγκος (''ónkos''), meaning "tumor", "volume" or "mass". Oncology is concerned with: * The diagnosis of any cancer in a person (pathology) * Therapy (e.g. surgery, chemotherapy, radiotherapy and other modalities) * Follow-up of cancer patients after successful treatment * Palliative care of patients with terminal malignancies * Ethical questions surrounding cancer care * Screening efforts: ** of populations, or ** of the relatives of patients (in types of cancer that are thought to have a hereditary basis, such as breast cancer) Diagnosis Medical histories remain an important screening tool: the character of the complaints and nonspecific symptoms (such as fatigue, weight loss, unexplained anemia, fever of unknown origin, paraneoplastic phenome ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
NCI-designated Cancer Center
NCI-designated Cancer Centers are a group of 71 cancer research institutions in the United States supported by the National Cancer Institute. Program Three designations are recognized: Comprehensive Cancer Centers, Clinical Cancer Centers, and Basic Laboratory Cancer Centers. As of 2022, there are 52 Comprehensive Cancer Centers, 12 Clinical Cancer Centers, and 7 Basic Laboratory Cancer Centers. Almost all are associated with a university. Receiving the NCI-designation places cancer centers among the top 4 percent of the approximately 1,500 cancer centers in the United States. The standards for ''Comprehensive Cancer Centers'' are the most restrictive of the types. These facilities must demonstrate expertise in each of three areas: laboratory, clinical, and behavioral and population-based research. Comprehensive Cancer Centers are expected to initiate and conduct early phase, innovative clinical trials and to participate in the NCI's cooperative groups by providing leadership and ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
National Comprehensive Cancer Network
National Comprehensive Cancer Network (NCCN) is an alliance of 32 cancer centers in the United States, most of which are designated by the National Cancer Institute (one of the U.S. National Institutes of Health) as comprehensive cancer centers. It is a non-profit organization with offices in Plymouth Meeting, Pennsylvania. John W. Sweetenham, MD, FRCP, FACP, FASCO, from UT Southwestern Simmons Comprehensive Cancer Center, is chairman of the NCCN Board of Directors. It publishes the peer-reviewed medical journal ''Journal of the National Comprehensive Cancer Network''. NCCN Member Institutions Experts from the 32 NCCN Member Institutions are recognized for dealing with complex, aggressive, or rare cancers. The 32 NCCN Member Institutions are: * Abramson Cancer Center at the University of Pennsylvania * Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine * Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Cente ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
National Cancer Institute
The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship. NCI is the oldest and has the largest budget and research program of the 27 institutes and centers of the NIH ($6.9 billion in 2020). It fulfills the majority of its mission via an extramural program that provides grants for cancer research. Additionally, the National Cancer Institute has intramural research programs in Bethesda, Maryland, and at the Frederick National Laboratory for Cancer Research at Fort Detrick in Frederick, Maryland. The NCI receives more than in funding each ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
List Of EORTC Trials
This page is a list of EORTC clinical trials sponsored by the European Organisation for Research and Treatment of Cancer (EORTC). Breast cancer * EORTC 10085 – characterization of male breast cancer * EORTC 10863 – continuous tamoxifen versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate * EORTC 10951 – exemestane versus tamoxifen Older studies * Nafoxidine versus ethinylestradiol * Levodopa versus nafoxidine Prostate cancer The following prostate cancer trials have been conducted, among others: * EORTC 30761 – cyproterone acetate 250 mg/day versus medroxyprogesterone acetate 200 mg/day versus diethylstilbestrol 3 mg/day * EORTC 30762 – estramustine phosphate 280 mg/day (560 mg/day initially) versus diethylstilbestrol 3 mg/day * EORTC 30805 – orchiectomy versus orchiectomy plus cyproterone acetate (150 mg/day) versus low-dose diethylstilbestrol (1 mg/day) * EORTC 30843 – orc ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Journal Of The National Cancer Institute
The ''Journal of the National Cancer Institute'' (''JNCI'') is a peer-reviewed medical journal covering research in oncology that was established in August 1940. It is published monthly by Oxford University Press and is edited by Patricia A. Ganz. It was merged with ''Cancer Treatment Reports'' in January 1988. ''JNCI'' used to be the official journal of the National Cancer Institute (NCI); however, in 1996, the NCI and ''JNCI'' agreed to grow apart. Over the next five years, ''JNCI'' became independent of the NCI. A related publication is ''Journal of the National Cancer Institute Monographs'' (''JNCI Monographs''), established in 1959, which publishes manuscripts from cancer and cancer-related conferences, as well as groups of papers on specific subjects related to cancer. In January 1986, ''Cancer Treatment Symposia'' was merged with ''JNCI Monographs''. Additionally, ''JNCI Cancer Spectrum'' (''JNCI CS'') is a fully open access journal, which was established in 2017. It is pub ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
International Agency For Research On Cancer
The International Agency for Research on Cancer (IARC; french: Centre International de Recherche sur le Cancer, CIRC) is an intergovernmental agency forming part of the World Health Organization of the United Nations. Its role is to conduct and coordinate research into the causes of cancer. It also collects and publishes surveillance data regarding the occurrence of cancer worldwide. Its IARC monographs programme identifies carcinogenic hazards and evaluates environmental causes of cancer in humans. IARC has its own governing council, and in 1965 the first members were the Federal Republic of Germany, France, Italy, the United Kingdom, and the United States of America. Today, IARC's membership has grown to 27 countries. History In late February 1963, after he experienced his spouse suffering and dying of cancer, journalist and peace activist Yves Poggioli sent a letter to Emmanuel d'Astier de la Vignerie relating his story, and urging support for the creation of an intern ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Federation Of European Cancer Societies
The Federation of European Cancer Societies (FECS), founded in 1981, was an international non-profit association that co-ordinated collaboration between European societies active in different fields of cancer research, prevention and treatment with the ultimate goal of providing the best possible treatment and care for all European cancer patients. After consulting many professionals in the oncology community, FECS was transformed into the European Cancer Organisation in 2007. See also * European Cancer Organisation External links European Cancer Organisation {{authority control Cancer organizations European medical and health organizations ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Canadian Cancer Society
The Canadian Cancer Society (french: Société canadienne du cancer) is Canada's largest national cancer charity and the largest national charitable funder of cancer research in Canada. History The idea to form the Canadian Cancer Society originally came from the Saskatchewan Medical Association in 1929, when they formed Canada's first cancer committee. In 1937, the National Study Committee recommended the formation of new organization, which was later called Canadian Cancer Society for the Control of Cancer. The Canadian Cancer Society (CCS) was officially formed a decade later, in 1938, to educate Canadians about the early warning signs of cancer. At that time, many people did not seek medical help until their cancer had advanced past a treatable stage. In 1947, CCS began funding cancer research through the creation of the National Cancer Institute of Canada, an agreement between the Canadian Cancer Society and the Federal Department of Health and Welfare. The Society continu ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
CaBIG
The cancer Biomedical Informatics Grid (caBIG) was a US government program to develop an open-source, open access information network called caGrid for secure data exchange on cancer research. The initiative was developed by the National Cancer Institute (part of the National Institutes of Health) and was maintained by the Center for Biomedical Informatics and Information Technology (CBIIT). In 2011 a report on caBIG raised significant questions about effectiveness and oversight, and its budget and scope were significantly trimmed. In May 2012, the National Cancer Informatics Program (NCIP) was created as caBIG's successor program. History The National Cancer Institute (NCI) of the United States funded the cancer Biomedical Informatics Grid (caBIG) initiative in spring 2004, headed by Kenneth Buetow. Its goal was to connect US biomedical cancer researchers using technology known as grid computing. The program, led by the Center for Bioinformatics and Information Technology (CBI ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
